
FHI 360 is owned by no one; it is an independent 501(c)(3) nonprofit organization governed by a board of directors, with no parent company or shareholders. The organization was founded in 1971 at the University of North Carolina at Chapel Hill and took its current form in 2011 through the merger of Family Health International and the Academy for Educational Development. It is headquartered in Durham, North Carolina.
| Brand | Parent Company | Ownership Type |
|---|---|---|
| FHI 360 | FHI 360 | Brand division |
FHI 360 traces its founding to 1971 at the University of North Carolina at Chapel Hill, where it began as the International Fertility Research Program conducting research on family planning and reproductive health. It later became Family Health International, expanding through the 1980s into one of the world's largest HIV and AIDS research and program portfolios as the epidemic spread.
In 1990 the organization established the FHI Foundation using proceeds from the sale of two for-profit companies, creating an internal engine for new initiatives. The name simplified to FHI in 2010 as the mission broadened beyond health into wider development work.
The defining structural event came in 2011, when FHI acquired the programs, expertise, and assets of the Academy for Educational Development, a Washington-based nonprofit with more than 100 programs across the US and over 50 countries. The merger created FHI 360, adding education, nutrition, economic development, civil society, and youth work to the health portfolio.
For more than a decade FHI 360 operated as one of the largest nonprofit implementers of US foreign assistance, with USAID its dominant funder, receiving the third-most USAID funding of any nongovernmental organization between 2013 and 2022.
The environment changed abruptly in 2025. The Trump administration's dismantling of USAID eliminated roughly half of FHI 360's revenue and forced it to furlough and then permanently lay off more than 1,100 staff, including 483 US employees and more than 700 overseas, while cutting over 70 projects. Senior leaders took steep salary reductions to preserve the organization. Fiscal 2025 revenue fell to $566.6 million from $820.4 million the prior year, with the US government share dropping from $702 million to $446 million.
What does FHI 360 own?
As a nonprofit it has programs rather than owned brands in the commercial sense. It operates the FHI 360 masterbrand, the FHI Clinical subsidiary, and the internal FHI Foundation.
Is FHI 360 publicly traded?
No. FHI 360 is a nonprofit organization with no shares and no stock listing.
Who founded FHI 360?
It grew out of a 1971 research program at the University of North Carolina at Chapel Hill rather than named individual founders. The modern organization formed in 2011 through the merger of Family Health International and the Academy for Educational Development.
Where is FHI 360 headquartered?
Durham, North Carolina, USA, at the American Tobacco Campus, with a major office in Washington, DC.
How many brands does FHI 360 own?
It operates one masterbrand with associated programs and a clinical research subsidiary rather than a portfolio of consumer brands.
Who owns FHI 360?
No one. It is an independent 501(c)(3) governed by a board of directors, funded by governments, foundations, corporations, and multilateral agencies.
What is FHI 360's revenue?
$566.6 million in fiscal 2025 ended September 30, 2025, down from $820.4 million the prior year after the closure of USAID eliminated roughly half its funding.
FHI 360's recognition comes from its research record rather than rankings. It was the third-largest recipient of USAID funding among NGOs from 2013 to 2022, a measure of its standing with the agency, and it has been a leading implementer of US government HIV/AIDS programming under PEPFAR for decades. Its researchers publish regularly in major medical and public health journals, and the organization is frequently cited in policy work on global health and development.
The dominant event in FHI 360's recent record is the 2025 USAID collapse rather than a self-inflicted controversy. The closure of its largest funder forced layoffs of more than 1,100 staff, the cancellation of more than 70 projects, salary cuts including a reported 47 percent reduction for the CEO, and a halving of revenue in one fiscal year. These were consequences of a policy decision, not organizational misconduct.
Like most large USAID implementers, FHI 360 has at times drawn scrutiny from congressional and watchdog reviews of foreign assistance spending, but no fraud findings, major lawsuits, or regulatory sanctions are on record.
No direct competitors found in the same category. This could be because FHI 360operates in a unique market segment or we're still building our competitor database.
Looking for brands with different ownership structures? These similar brands are not owned by FHI 360, giving you alternative choices that support different corporate structures.
Healthcare PharmaceuticalsOwned by Mayo Clinic
Mayo Clinic is a nonprofit American academic medical center headquartered in Rochester, Minnesota, consistently ranked among the top hospitals in the world.
Mayo Clinic operates independently without a large parent corporation.
Healthcare PharmaceuticalsOwned by Pfizer Inc.
American multinational pharmaceutical corporation developing and manufacturing medicines, vaccines, and consumer healthcare products, one of the world's largest pharmaceutical companies.
Pfizer operates independently without a large parent corporation.
Healthcare PharmaceuticalsOwned by ADARx Pharmaceuticals, Inc.
Biotechnology brand of ADARx Pharmaceuticals, the San Diego siRNA company that listed on Nasdaq in September 2026.
ADARx operates independently without a large parent corporation.
Healthcare PharmaceuticalsOwned by Adcock Ingram Holdings Limited
South African pharmaceutical brand behind Panado and Myprodol, now privately held by Bidvest and NATCO Pharma.
Adcock Ingram operates independently without a large parent corporation.
Healthcare PharmaceuticalsOwned by Alcon Inc.
Independent publicly traded global eye care company headquartered in Geneva, Switzerland, specializing in surgical equipment, contact lenses, and ophthalmic products. Spun off from Novartis in April 2019.
Alcon operates independently without a large parent corporation.
Healthcare PharmaceuticalsOwned by Amgen Inc.
Master biotechnology brand of Amgen Inc., the world's largest independent biotech, covering its full portfolio of biologic medicines.
Amgen operates independently without a large parent corporation.
Discover popular brands and companies in the Healthcare & Pharmaceuticals category and related searches from other users.

Consumer DNA testing brand now run as a nonprofit under TTAM Research Institute following the 2025 bankruptcy sale of 23andMe Holding Co.

Abbokinase (urokinase) is a thrombolytic medication historically used for pulmonary embolism and catheter clearance. Originally marketed by Abbott Laboratories, now owned by Microbix Biosystems as Kinlytic. FDA-approved since 1978.

Abbott Laboratories' medical device business spanning cardiovascular, diabetes care (FreeStyle Libre), neuromodulation, and structural heart, generating roughly $20 billion annually.